$3.54T
Total marketcap
$120.33B
Total volume
BTC 60.40%     ETH 9.31%
Dominance

Amgen AMGN Stock

278.4 USD {{ price }} -0.375745% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
150.26B USD
LOW - HIGH [24H]
276.62 - 281.34 USD
VOLUME [24H]
3.86M USD
{{ volume }}
P/E Ratio
25.37
Earnings per share
10.97 USD

Amgen Price Chart

Amgen AMGN Financial and Trading Overview

Amgen stock price 278.4 USD
Previous Close 222.28 USD
Open 223.01 USD
Bid 0 USD x 900
Ask 0 USD x 800
Day's Range 222.97 - 228.85 USD
52 Week Range 211.71 - 296.67 USD
Volume 2.63M USD
Avg. Volume 2.34M USD
Market Cap 122.06B USD
Beta (5Y Monthly) 0.642957
PE Ratio (TTM) 15.529572
EPS (TTM) 10.97 USD
Forward Dividend & Yield 8.52 (3.83%)
Ex-Dividend Date May 17, 2023
1y Target Est 254.55 USD

AMGN Valuation Measures

Enterprise Value 148.8B USD
Trailing P/E 15.529572
Forward P/E 12.125265
PEG Ratio (5 yr expected) 7.25
Price/Sales (ttm) 4.6606207
Price/Book (mrq) 22.82346
Enterprise Value/Revenue 5.682
Enterprise Value/EBITDA 11.34

Trading Information

Amgen Stock Price History

Beta (5Y Monthly) 0.642957
52-Week Change -2.67%
S&P500 52-Week Change 20.43%
52 Week High 296.67 USD
52 Week Low 211.71 USD
50-Day Moving Average 232.81 USD
200-Day Moving Average 248.07 USD

AMGN Share Statistics

Avg. Volume (3 month) 2.34M USD
Avg. Daily Volume (10-Days) 2.42M USD
Shares Outstanding 534.33M
Float 533.2M
Short Ratio 3.21
% Held by Insiders 0.21%
% Held by Institutions 79.82%
Shares Short 7.41M
Short % of Float 1.38%
Short % of Shares Outstanding 1.38%

Dividends & Splits

Trailing Annual Dividend Rate 7.95
Trailing Annual Dividend Yield 3.57%
5 Year Average Dividend Yield 288.00%
Payout Ratio 0.5404
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 30.22%
Operating Margin (ttm) 36.83%
Gross Margin 74.93%
EBITDA Margin 50.10%

Management Effectiveness

Return on Assets (ttm) 8.15%
Return on Equity (ttm) 252.77%

Income Statement

Revenue (ttm) 26.19B USD
Revenue Per Share (ttm) 49 USD
Quarterly Revenue Growth (yoy) -2.10%
Gross Profit (ttm) 19.92B USD
EBITDA 13.12B USD
Net Income Avi to Common (ttm) 7.92B USD
Diluted EPS (ttm) 14.71
Quarterly Earnings Growth (yoy) 92.50%

Balance Sheet

Total Cash (mrq) 31.56B USD
Total Cash Per Share (mrq) 59.07 USD
Total Debt (mrq) 61.6B USD
Total Debt/Equity (mrq) 1151.74 USD
Current Ratio (mrq) 3.145
Book Value Per Share (mrq) 10.009

Cash Flow Statement

Operating Cash Flow (ttm) 8.62B USD
Levered Free Cash Flow (ttm) 7.95B USD

Profile of Amgen

Country United States
State CA
City Thousand Oaks
Address One Amgen Center Drive
ZIP 91320-1799
Phone 805 447 1000
Website https://www.amgen.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 25200

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Q&A For Amgen Stock

What is a current AMGN stock price?

Amgen AMGN stock price today per share is 278.4 USD.

How to purchase Amgen stock?

You can buy AMGN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Amgen?

The stock symbol or ticker of Amgen is AMGN.

Which industry does the Amgen company belong to?

The Amgen industry is Drug Manufacturers-General.

How many shares does Amgen have in circulation?

The max supply of Amgen shares is 539.73M.

What is Amgen Price to Earnings Ratio (PE Ratio)?

Amgen PE Ratio is 25.37830400 now.

What was Amgen earnings per share over the trailing 12 months (TTM)?

Amgen EPS is 10.97 USD over the trailing 12 months.

Which sector does the Amgen company belong to?

The Amgen sector is Healthcare.

Amgen AMGN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 19100.94 USD
-0.51
7.61B USD 19084.38 USD 19276.83 USD 7.61B USD
S&P 500 INDEX SPX 5888.55 USD
-0.56
2.64B USD 5881.88 USD 5939.92 USD 2.64B USD
S&P 500 (Yahoo.com) GSPC 5888.55 USD
-0.56
2.61B USD 5881.88 USD 5939.92 USD 2.61B USD
S&P 100 SP100 2870.78 USD
-0.43
1.22B USD 2867.4 USD 2895.46 USD 1.22B USD
US100 NDX 21318.17 USD
-0.45
1.13B USD 21296.51 USD 21508.08 USD 1.13B USD
Dow Jones Industrial Average DJI 42098.7 USD
-0.58
518.84M USD 42042.26 USD 42448.72 USD 518.84M USD
Dow Jones U.S. Biotechnology In DJUSBT 2489.61 USD
-0.72
97.11M USD 2482.71 USD 2516.71 USD 97.11M USD
Nasdaq US Low Volatility Divide LVDA 1253.72 USD
-0.84
1251.78 USD 1265.69 USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1339.86 USD
-0.83
1334.96 USD 1352.59 USD
Nasdaq Health Care IXHC 941.34 USD
-0.51
940.07 USD 947.81 USD
NASDAQ Global Select Market Com NQGS 9347.78 USD
-0.51
9339.71 USD 9434.23 USD
NASDAQ-100 Pre Market Indicator QMI 21437.38 USD
+0.1
21437.38 USD 21479.51 USD
NASDAQ Global BuyBack Achievers DRBG 2378.7 USD
-0.79
2377.79 USD 2378.79 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD
The Capital Strength Net Total NQCAPSTN 3892.56 USD
-0.93
3890.04 USD 3935.4 USD
Better Investing 100 BIXX 245.36 USD
0
NASDAQ-100 Ex-Tech Sector NDXX 5843.23 USD
-0.42
5836.04 USD 5881.79 USD
NASDAQ-100 PM Settlement Value XQC 16331.98 USD
+1.13
16331.98 USD 16331.98 USD
Nasdaq-100 ESG JPY Index NDXESG07 2053.8 JPY 13.86 USD
-0.14
2051.92 JPY 13.85 USD 2073.53 JPY 14 USD
NASDAQ-100 Notional Net Total R XNDXNNR 24700.74 USD
-0.45
24675.65 USD 24920.79 USD